Whole Exome Sequencing Seeks Out Adenoid Cystic Carcinoma

Date: Jun-19-2013Adenoid cystic carcinoma (ACC) is a slow-growing and often fatal malignancy that can occur at multiple organ sites, but is most frequently found in the salivary glands. The primary treatment is surgical removal; however, the majority of patients develop metastatic disease.

In this issue of the
Journal of Clinical Investigation, researchers led by Andrew Futreal at the Wellcome Trust Sanger Institute in Cambridge, MA, performed a type of genetic sequencing known as whole exome sequencing of 24 ACC cases. They identified a genetic translocation that can precipitate disease and determined that a large number of disease-associated mutations occurred in genes that modify DNA.

In the accompanying commentary, Henry Frierson, Jr. of the University of Virginia emphasizes that identifying individual mutations will aid the development of personalized therapy.

TITLE: Whole exome sequencing of adenoid cystic carcinoma

View this article at: http://www.jci.org/articles/view/67201?key=d9e8a757b7c521272b6f

ACCOMPANYING COMMENTARY
TITLE: Mutation signature of adenoid cystic carcinoma: evidence for transcriptional and epigenetic reprogramming

View this article at: http://www.jci.org/articles/view/69070?key=b1da65c50c2dc7a2e200
Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.